Papers by S M Jun · AgingResearch.News

Diabetes, Obesity & Metabolism6 Oct
A 52-Week Efficacy and Safety Study of Teneligliptin, as an Add-On to Empagliflozin and Metformin in Patients With Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial (TERA305 Study)
Trial in peopleInterventions
Paper
Journal of Korean Medical Science22 Sep
Sex-Specific Cut-off Values for Respiratory Muscle Strength in Older Women: Screening Implications for Respiratory Sarcopenia
Cross-sectional study of 88 peopleGrip strength
Paper
Journal of Korean Medical Science15 Sep
Home-Based Cardiac Rehabilitation Using a Smart Ring and Telephone Counselling: A Randomized Controlled Trial
Trial in peopleInterventions
Paper
Frontiers in Aging Neuroscience4 Aug
Memory training through Chinese classics recitation for individuals with subjective cognitive decline: study protocol for a pilot study
Study protocolCognitive training
Paper

ADA Scientific Sessions 2026 Abstract5 Jun
Efficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 25 mg in Patients with Type 2 Diabetes: A 24-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with 28-Week Open-Label Extension
Trial in peopleInterventions
Paper